Genmab — November 2016
-
Det er bare en halvtrist dag for mange aktier. Ingen grund til at lægge noget særligt i det lille tilbagefald i aktien.
-
Det sker under lav omsætning.
-
1240 er den afgørende modstand aktien meget gerne skal etablere sig over.
-
At vi ryger under intraday betyder ikke noget.
-
dont see anything for us... https://ash.confex.com/ash/2016/webprogram/Session8527.html
-
pre-ash: What Myeloma Patients & Caregivers Need to Know, summary by IMF’s Chairman of the Board Dr. Durie, Nov17
https://www.myeloma.org/videos/pre-ash-what-myeloma-patients-caregivers-need-know
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind